Armando Tejerina
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Protease and Inhibitor Mechanisms
-
- Drug Transport and Resistance Mechanisms
- Neutropenia and Cancer Infections
Papers in
-
- Breast Cancer Treatment Studies 24
- Protease and Inhibitor Mechanisms 2
-
- Breast Lesions and Carcinomas 13
- Co-authors
- José Schneider (22 shared papers)Á. Ruibal (20 shared papers)Fernando Martínez‐Arribas (7 shared papers)Marina Pollán (3 shared papers)M Casado Martín (2 shared papers)José Ignacio Arias (11 shared papers)Severino González-Roces (1 shared paper)Fernando Bandrés (2 shared papers)
- Journals
- The International Journal of Biological Markers (4 papers)Breast Cancer Research (2 papers)Tumor Biology (1 paper)British Journal of Cancer (1 paper)British journal of surgery (1 paper)
- Partner nations
- Spain
In The Last Decade
Armando Tejerina
31 papers receiving 394 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 195
- Oncology 108
- Pharmacology 38
- Pathology and Forensic Medicine 45
- Otorhinolaryngology 5
Countries citing papers authored by Armando Tejerina
This map shows the geographic impact of Armando Tejerina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armando Tejerina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armando Tejerina more than expected).
Fields of papers citing papers by Armando Tejerina
This network shows the impact of papers produced by Armando Tejerina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armando Tejerina. The network helps show where Armando Tejerina may publish in the future.
Co-authors
The 23 scholars most cited alongside Armando Tejerina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 53 | |
| 2 | 2001 | 45 | |
| 3 | Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP. | 2001 | 43 |
| 4 | 2013 | 38 | |
| 5 | Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level. | 2007 | 34 |
| 6 | 2010 | 30 | |
| 7 | 1999 | 29 | |
| 8 | 2003 | 25 | |
| 9 | Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases. | 2002 | 23 |
| 10 | 2001 | 21 | |
| 11 | Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. | 2003 | 19 |
| 12 | Bax expression in untreated breast cancer: an immunocytometric study of 255 cases. | 2008 | 8 |
| 13 | 2013 | 8 | |
| 14 | [Clinical-biological differences between invasive ductal carcinomas and breast lobular carcinomas. Preliminary results]. | 1999 | 5 |
| 15 | 2000 | 5 | |
| 16 | Cellular accumulation of uPA-PAI-1 [correction of UPA-PAI-1] and uPA-PAI-2 [correction of UPA-PAI-2] complexes in early (pT1) breast cancer: a new link in the uPA-UPAr-PAI chain. | 2000 | 5 |
| 17 | Proliferation measurement in breast cancer by two different methods. | 2006 | 5 |
| 18 | 1999 | 4 | |
| 19 | 2005 | 4 | |
| 20 | Molecular subgroups of small (pT1) breast carcinomas belonging exclusively to the ductal infiltrating variety. | 2008 | 4 |
About Armando Tejerina
Armando Tejerina is a scholar working on Cancer Research, Pathology and Forensic Medicine, Cell Biology, Oncology and Pharmacology, having authored 35 papers that have together received 428 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), Breast Lesions and Carcinomas (13 papers), Proteoglycans and glycosaminoglycans research (3 papers), Protease and Inhibitor Mechanisms (2 papers), Cell death mechanisms and regulation (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Body Composition Measurement Techniques (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Cancer Research (195 citations), Oncology (108 citations), Pharmacology (38 citations), Pathology and Forensic Medicine (45 citations) and Otorhinolaryngology (5 citations). Armando Tejerina has collaborated with scholars based in Spain. Frequent co-authors include José Schneider, Á. Ruibal, Fernando Martínez‐Arribas, Marina Pollán, M Casado Martín, José Ignacio Arias, Severino González-Roces, Fernando Bandrés, Ana Fernández‐Santander and Apolonia Novillo. Their work appears in journals such as The International Journal of Biological Markers, Breast Cancer Research, Tumor Biology, British Journal of Cancer and British journal of surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.